AGENDA

  CIRCULATORY SYSTEM DEVICES PANEL

January 13, 2005

              Hilton Gaithersburg Washington D.C./North, Salons A, B  & C, 620 Perry Parkway, Gaithersburg, MD. 

9:00 – 5:00     PMA Discussion and Recommendations

 

9:00 a.m.                        Call to Order                         William H. Maisel, M.D., M.P.H.

                                                                        Acting Chairperson

9:05 – 9:20  a.m.                        FDA Presentation - Critical Path Initiative

                        Dr. Binita Ashar; Acting Clinical Director; CDRH

 

9:20 – 9:35 a.m.                        FDA Presentation – Panel Update 

                        Megan Moynahan; Branch Chief; Pacing, Defibrillator Leads Branch; CDRH

 

9:35 – 10:05 a.m.                        *Open Public Session*

 

10:05 – 11:05 a.m.                         Sponsor Presentation:  W.L. Gore & Associates, Inc.

P040043: Gore TAG Thoracic Endoprosthesis

11:05 – 11:20 a.m.                        Questions and Answers

 

11:20 – 11:30 a.m.                        Break

 

11:30 – 12:30 p.m.                        FDA Presentation

12:30 – 12:45 p.m.                        Questions and Answers

 

12:45 p.m.       Adjourn – Break for Lunch

 

1:45 p.m.                            Call to Order                                 

1:45 – 3:45 p.m.                        Open Committee Discussion                        William H. Maisel, M.D.

 

3:45 – 4:00 p.m.                            Break

 

4:00 – 5:00 p.m.                                  *Open Public Session*

                            FDA Comments

                        Sponsor Comments

                        Recommendations & Vote                           William H. Maisel, M.D.

 

5:00 p.m.                        Adjourn

 

 

OPEN PUBLIC HEARINGS*

Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.  

 

Ms. Wood will present the speakers who have requested time for presentation to the Panel.  After the scheduled speakers have spoken, the Chair may ask them to remain if the committee wishes to question them further.  Dr. Maisel will recognize unscheduled speakers as time allows.

 

Note: Only the Chair and members of the Panel may question speakers during the open public hearing.